Notice: This company has been marked as potentially delisted and may not be actively trading. Principal Healthcare Innovators ETF (BTEC) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisHeadlinesHoldingsOwnershipRatingsTrends Principal Healthcare Innovators ETF Short Interest DataPrincipal Healthcare Innovators ETF (BTEC) has a short interest of 1,500 shares. This marks a -6.25% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 7,863 shares to cover all short positions.Current Short Interest1,500 sharesPrevious Short Interest1,600 sharesChange Vs. Previous Month-6.25%Dollar Volume Sold Short$60,090.00Short Interest Ratio0.1 Days to CoverLast Record DateJuly 15, 2024Outstanding Shares410,000 sharesPercentage of Shares Shorted0.37%Today's Trading Volume0 sharesAverage Trading Volume7,863 sharesToday's Volume Vs. Average0% Short Selling Principal Healthcare Innovators ETF? Sign up to receive the latest short interest report for Principal Healthcare Innovators ETF and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBTEC Short Interest Over TimeBTEC Days to Cover Over TimeBTEC Percentage of Float Shorted Over Time Principal Healthcare Innovators ETF Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/20241,500 shares $60,090.00 -6.3%N/A0.1 $40.06 6/30/20241,600 shares $58,320.00 -5.9%N/A0.1 $36.45 6/15/20241,700 shares $61,800.78 +1,600.0%N/A0.1 $36.35 5/31/2024100 shares $3,597.00 -92.3%N/A0 $35.97 5/15/20241,300 shares $48,100.00 -66.7%N/A0.2 $37.00 4/30/20243,900 shares $135,486.00 +14.7%N/A0.8 $34.74 4/15/20243,400 shares $119,238.00 -10.5%N/A0.6 $35.07 3/31/20243,800 shares $144,476.00 +11.8%N/A0.8 $38.02 3/15/20243,400 shares $125,494.00 No ChangeN/A0.7 $36.91 2/29/20243,400 shares $131,172.00 +13.3%N/A1 $38.58 Get the Latest News and Ratings for BTEC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Principal Healthcare Innovators ETF and its competitors with MarketBeat's FREE daily newsletter. 2/15/20243,000 shares $114,270.00 -25.0%N/A0.9 $38.09 1/31/20244,000 shares $142,960.00 No ChangeN/A1.2 $35.74 5/15/20238,000 shares $298,720.00 No ChangeN/A4.4 $37.34 9/15/2022400 shares $15,040.00 No ChangeN/A0.1 $37.60 8/31/2022400 shares $14,488.00 -50.0%N/A0.1 $36.22 8/15/2022800 shares $32,354.72 -82.2%N/A0.2 $40.44 7/31/20224,500 shares $158,490.00 -13.5%N/A1.1 $35.22 7/15/20225,200 shares $181,740.00 No ChangeN/A1 $34.95 4/30/2022100 shares $3,293.00 No ChangeN/A0 $32.93 4/15/2022100 shares $3,881.00 No ChangeN/A0 $38.81 3/31/2022100 shares $4,008.00 No ChangeN/A0 $40.08 3/15/2022100 shares $3,535.00 -50.0%N/A0 $35.35 2/28/2022200 shares $7,818.00 +100.0%N/A0 $39.09 2/15/2022100 shares $4,086.91 -94.1%N/A0 $40.87 1/31/20221,700 shares $66,929.00 +1,600.0%N/A0.1 $39.37 1/15/2022100 shares $4,138.65 -75.0%N/A0 $41.39 12/31/2021400 shares $18,916.00 +300.0%N/A0 $47.29 12/15/2021100 shares $4,754.00 -90.9%N/A0 $47.54 11/30/20211,100 shares $53,262.00 +266.7%N/A0.1 $48.42 11/15/2021300 shares $15,990.00 -25.0%N/A0 $53.30 10/29/2021400 shares $21,716.00 -81.8%N/A0.1 $54.29 10/15/20212,200 shares $119,968.20 +450.0%N/A0.3 $54.53 9/30/2021400 shares $21,852.00 -63.6%N/A0 $54.63 9/15/20211,100 shares $62,062.00 +266.7%N/A0.1 $56.42 8/31/2021300 shares $17,315.10 -80.0%N/A0 $57.72 8/13/20211,500 shares $81,570.00 -34.8%N/A0.1 $54.38 7/30/20212,300 shares $128,524.00 -78.7%N/A0.1 $55.88 7/15/202110,800 shares $598,320.00 -9.2%N/A0.5 $55.40 6/30/202111,900 shares $724,472.00 +14.4%N/A0.8 $60.88 6/15/202110,400 shares $612,768.00 +316.0%N/A0.7 $58.92Do this Before Elon’s Reveal on April 23rd (Ad)Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.I urge you to watch this video now. 5/28/20212,500 shares $140,000.00 -43.2%N/A0.2 $56.00 5/14/20214,400 shares $225,505.72 -18.5%N/A0.2 $51.25 4/30/20215,400 shares $326,754.00 -52.2%N/A0.3 $60.51 4/15/202111,300 shares $656,982.00 +1,514.3%N/A0.5 $58.14 3/31/2021700 shares $38,816.33 -94.9%N/A0 $55.45 3/15/202113,600 shares $829,464.00 -47.1%N/A0.5 $60.99 2/26/202125,700 shares $1.59 million +634.3%N/A1 $62.04 2/12/20213,500 shares $242,585.00 -22.2%N/A0.1 $69.31 1/29/20214,500 shares $283,050.00 +246.2%N/A0.2 $62.90 1/15/20211,300 shares $83,408.00 No ChangeN/A0.1 $64.16 BTEC Short Interest - Frequently Asked Questions What is Principal Healthcare Innovators ETF's current short interest? Short interest is the volume of Principal Healthcare Innovators ETF shares that have been sold short but have not yet been covered or closed out. As of July 15th, traders have sold 1,500 shares of BTEC short. Learn More on Principal Healthcare Innovators ETF's current short interest. Is Principal Healthcare Innovators ETF's short interest increasing or decreasing? Principal Healthcare Innovators ETF saw a drop in short interest in the month of July. As of July 15th, there was short interest totaling 1,500 shares, a drop of 6.3% from the previous total of 1,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Principal Healthcare Innovators ETF's short interest compare to its competitors? Here is how the short interest of companies compare to Principal Healthcare Innovators ETF: First Trust Nasdaq Pharmaceuticals ETF (0.16%), JPMorgan Healthcare Leaders ETF (0.13%), ProShares UltraShort Nasdaq Biotechnology (5.90%), Invesco Nasdaq Biotechnology ETF (0.16%), ProShares Ultra Nasdaq Biotechnology (0.44%), Invesco Dorsey Wright Healthcare Momentum ETF (0.10%), VanEck Biotech ETF (0.06%), VanEck Pharmaceutical ETF (53.37%), and iShares Biotechnology ETF (23.69%). Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.13 billion), Royal Caribbean Cruises Ltd. ($2.77 billion), Moderna, Inc. ($2.76 billion), Coinbase Global, Inc. ($2.36 billion), Rivian Automotive, Inc. ($2.22 billion), Paychex, Inc. ($2.02 billion), Tractor Supply ($1.81 billion), Enphase Energy, Inc. ($1.65 billion), Chesapeake Energy Co. ($1.62 billion), and Lululemon Athletica Inc. ($1.58 billion). View all of the most shorted stocks. What does it mean to sell short Principal Healthcare Innovators ETF stock? Short selling BTEC is an investing strategy that aims to generate trading profit from Principal Healthcare Innovators ETF as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Principal Healthcare Innovators ETF? A short squeeze for Principal Healthcare Innovators ETF occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BTEC, which in turn drives the price of the stock up even further. How often is Principal Healthcare Innovators ETF's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BTEC, twice per month. The most recent reporting period available is July, 15 2024. More Short Interest Resources from MarketBeat Related Companies First Trust Nasdaq Pharmaceuticals ETF Short Squeeze JPMorgan Healthcare Leaders ETF Short Squeeze ProShares UltraShort Nasdaq Biotechnology Short Squeeze Invesco Nasdaq Biotechnology ETF Short Squeeze ProShares Ultra Nasdaq Biotechnology Short Squeeze Invesco Dorsey Wright Healthcare Momentum ETF Short Squeeze VanEck Biotech ETF Short Squeeze VanEck Pharmaceutical ETF Short Squeeze iShares Biotechnology ETF Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BTEC) was last updated on 1/30/2025 by MarketBeat.com Staff From Our PartnersTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredIs Big Tech dead?China just threw a “$5.5 million” curveball called Deep Seek to Silicon Valley and the timing of it is no coin...Brownstone Research | SponsoredElon’s ultimate power move?THE ELON SHOCK All of Elon Musk’s strange behavior may soon make sense… and impact the markets in a way no ...Altimetry | SponsoredDonald Trump is about to free crypto from its chains …On October 25th, Juan said Bitcoin would cross $100,000 before the inauguration. Now he thinks it could rea...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredPlease take this warning seriously...I’m here to issue a stark warning to you about an unexpected $2 trillion shock that could impact every trader ...Timothy Sykes | SponsoredHot Stock Alert! Biotech innovator on the NYSE announces breakthrough antiviral therapyA revolutionary antiviral drug is here! This breakthrough could mean viruses are unlikely to escape treatment....Smallcaps Daily | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Principal Healthcare Innovators ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Principal Healthcare Innovators ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.